TY - JOUR
T1 - Excessive daytime sleepiness and napping in cognitively normal adults
T2 - Associations with subsequent amyloid deposition measured by PiB PET
AU - Spira, Adam P.
AU - An, Yang
AU - Wu, Mark N.
AU - Owusu, Jocelynn T.
AU - Simonsick, Eleanor M.
AU - Bilgel, Murat
AU - Ferrucci, Luigi
AU - Wong, Dean F.
AU - Resnick, Susan M.
N1 - Funding Information:
This study was supported in part by the Intramural Research Program (IRP), National Institute on Aging (NIA), National Institutes of Health (NIH), and by Research and Development Contract HHSN-260-2004-00012C. NIA IRP NIH Investigators were involved in all aspects of this manuscript, including the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication. Dr. Spira is supported in part by AG050507, AG050745, and AG049872 from the National Institute on Aging. Ms. Owusu is supported in part by AG050507-02S1. Dr. Wong is supported in part by AG050507, AG050745, AG056142, AG040282, U19 AG033655, and contracts with Lilly/AVID, Lundbeck, Roche, and ADNI-3. Dr. Wong has received grant/ research support from Roche, Johnson & Johnson, and DART Neuroscience. The NIA Extramural Research Program played no role in the study design or conduct, or in data collection, management, analysis, or interpretation, or in manuscript preparation, review or approval, or decision to submit the manuscript for publication. No other disclosures were reported. Conflict of interest statement. Dr. Spira agreed to serve as a consultant to Awarables, Inc. in support of an NIH grant. Dr. Wong is supported in part by contracts with Lilly/AVID and grant/ research support from Johnson & Johnson.
Publisher Copyright:
© Published by Oxford University Press on behalf of Sleep Research Society (SRS) 2018.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Study Objectives To determine the association of excessive daytime sleepiness (EDS) and napping with subsequent brain β-amyloid (Aβ) deposition in cognitively normal persons. Methods We studied 124 community-dwelling participants in the Baltimore Longitudinal Study of Aging Neuroimaging Substudy who completed self-report measures of EDS and napping at our study baseline and underwent [ 11 C] Pittsburgh compound B positron emission tomography (PiB PET) scans of the brain, an average ±standard deviation of 15.7 ± 3.4 years later (range 6.9 to 24.6). Scans with a cortical distribution volume ratio of >1.06 were considered Aβ-positive. Results Participants were aged 60.1 ± 9.8 years (range 36.2 to 82.7) at study baseline; 24.4% had EDS and 28.5% napped. In unadjusted analyses, compared with participants without EDS, those with EDS had more than 3 times the odds of being Aβ+ at follow-up (odds ratio [OR] = 3.37, 95% confidence interval [CI]: 1.44, 7.90, p = 0.005), and 2.75 times the odds after adjustment for age, age 2, sex, education, and body mass index (OR = 2.75, 95% CI: 1.09, 6.95, p = 0.033). There was a trend-level unadjusted association between napping and Aβ status (OR = 2.01, 95% CI: 0.90, 4.50, p = 0.091) that became nonsignificant after adjustment (OR = 1.86, 95% CI: 0.73, 4.75, p = 0.194). Conclusions EDS is associated with more than 2.5 times the odds of Aβ deposition an average of 15.7 years later. If common EDS causes (e.g., sleep-disordered breathing, insufficient sleep) are associated with temporally distal AD biomarkers, this could have important implications for AD prevention.
AB - Study Objectives To determine the association of excessive daytime sleepiness (EDS) and napping with subsequent brain β-amyloid (Aβ) deposition in cognitively normal persons. Methods We studied 124 community-dwelling participants in the Baltimore Longitudinal Study of Aging Neuroimaging Substudy who completed self-report measures of EDS and napping at our study baseline and underwent [ 11 C] Pittsburgh compound B positron emission tomography (PiB PET) scans of the brain, an average ±standard deviation of 15.7 ± 3.4 years later (range 6.9 to 24.6). Scans with a cortical distribution volume ratio of >1.06 were considered Aβ-positive. Results Participants were aged 60.1 ± 9.8 years (range 36.2 to 82.7) at study baseline; 24.4% had EDS and 28.5% napped. In unadjusted analyses, compared with participants without EDS, those with EDS had more than 3 times the odds of being Aβ+ at follow-up (odds ratio [OR] = 3.37, 95% confidence interval [CI]: 1.44, 7.90, p = 0.005), and 2.75 times the odds after adjustment for age, age 2, sex, education, and body mass index (OR = 2.75, 95% CI: 1.09, 6.95, p = 0.033). There was a trend-level unadjusted association between napping and Aβ status (OR = 2.01, 95% CI: 0.90, 4.50, p = 0.091) that became nonsignificant after adjustment (OR = 1.86, 95% CI: 0.73, 4.75, p = 0.194). Conclusions EDS is associated with more than 2.5 times the odds of Aβ deposition an average of 15.7 years later. If common EDS causes (e.g., sleep-disordered breathing, insufficient sleep) are associated with temporally distal AD biomarkers, this could have important implications for AD prevention.
KW - aging
KW - biomarkers
KW - brain imaging
KW - epidemiology
KW - napping
KW - neurological disorders
KW - sleepiness
UR - http://www.scopus.com/inward/record.url?scp=85054893673&partnerID=8YFLogxK
U2 - 10.1093/sleep/zsy152
DO - 10.1093/sleep/zsy152
M3 - Article
C2 - 30192978
AN - SCOPUS:85054893673
SN - 0161-8105
VL - 41
JO - Sleep
JF - Sleep
IS - 10
ER -